| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Goldman Sachs analyst Mark Delaney maintains Cerence (NASDAQ:CRNC) with a Neutral and raises the price target from $10 to $11.
Cerence (NASDAQ:CRNC) lowers FY2026 sales outlook from $500.000 million to $300.000 million-$320.000 million vs $246.385 millio...
Cerence (NASDAQ:CRNC) sees Q1 sales of $110.000 million-$120.000 million vs $61.461 million analyst estimate.